Fact.MR – A Market Research and Competitive Intelligence Provider: As per the insights by Fact.MR, the global hysteroscopy systems market is poised to expand at a CAGR of 5% over the forecast period 2019-2029.
Over 80% of Revenue in Hysteroscopy Systems Market to Come from Top 5 Players
The hysteroscopy systems market study by Fact.MR offers compelling insights into drivers and restraints impacting the growth through 2031. The survey offers hysteroscopy systems demand outlook and studies opportunities existing in key segments, including product and modality. It also highlights key strategies adopted by market players to increase hysteroscopy systems sales.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per the insights by Fact.MR, the global hysteroscopy systems market is poised to expand at a CAGR of 5% over the forecast period 2019-2029.
The rising incidence of gynecological disorders such as polycystic ovary disease (PCOD) and uterine fibroids are propelling sales of hysteroscopy systems. As per a report, it is estimated that nearly 80% of women are affected by uterine fibroids during their lifetime.
According to the study, gradual shift in reimbursement policies has encouraged hysteroscopy integration office-based set-ups, presenting a positive demand outlook. As per a report by National Payment Amounts, consumer spending on hysteroscopy procedures performed in the office has grown threefold, accounting for an average of US$ 1,382.1 in 2017 as compared to US$ 409.6 in 2016.
Besides these, awareness campaigns such as “My hysteroscope is my Stethoscope” are pushing gynecologists to use hysteroscopy as a diagnostic tool.
Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=2577
Regionally, North America will emerge as a lucrative market owing to a growing preference for hysteroscopy procedures over traditional methods. Also, growth prospects are likely to remain positive in the Europe due to stringent regulations implemented to encourage the replacement of traditional methods with hysteroscopy in doctor’s offices.
For instance, in 2018, The U.S. Food and Drug Administration (FDA) ordered restrictions on sales and distribution of the Essure device to ensure all women using permanent contraception devices are provided with accurate risk information to make informed decisions.
“Leading market players are leveraging advanced technological integration and innovations to offer a highly precise and specific based diagnosis. This, in turn, is bolstering growth prospects for hysteroscopy systems,” says a Fact.MR analyst.
Key Takeaways from Hysteroscopy Systems Market Survey
- North America and Europe collectively accounted for nearly half of the market share in 2020.
- The top five players in the global hysteroscopy systems market are estimated to account for 80% of the overall market share.
- Based on end use, hospitals are channeling majority revenue on account of increasing cases of gynecological disorders.
- Over the forthcoming years, the hysteroscopy systems are expected to account for over 10% of the endoscopy systems market.
- Based on modality, handheld hysteroscopy systems to emerge as a potential segment.
Key Drivers
- Increasing cases of uterine cancers is driving the market growth.
- The hysteroscopy systems market is projected to grow at a rapid pace owing to advantages such as reduced hospital stay and fast recovery due to low blood loss.
Key Restraints
- Risk of pelvic inflammatory diseases may restrict the market growth.
Ask Your Hysteroscopy Systems Market Related Questions & Get Customized Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=2577
Competitive Landscape
Hysteroscopy systems manufacturers are focusing on expanding their portfolio by introducing novel hysteroscopy systems and accessories. Other players are also acquiring technology from competitors to enhance their product portfolio.
For instance, in 2016, Boston Scientific announced that it has signed a deal with Distal Access to acquire a single use device for resection of uterine polyps.
In 2016, Medtronic plc announced the acquisition of Smith & Nephew’s gynaecology business for nearly US$350 million.
Some of the leading players operating in the hysteroscopy systems market profiled by Fact.MR are:
- Boston Scientific Corporation
- Stryker Corporation
- Hologic Inc
- Olympus Corporation
- KARL STORZ GmbH & Co KG
More Valuable Insights on Hysteroscopy Systems Market
Fact.MR, in its new report, offers an unbiased analysis of the global hysteroscopy systems market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on hysteroscopy systems market with detailed segmentation:
Product
- Hysteroscopes
- Flexible Video Hysteroscopes
- Non-Video Hysteroscopes
- Rigid Non-Video Hysteroscopes
- Flexible Non-Video (Fiber) Hysteroscopes
- Hysteroscopy Fluid Management Systems
- Hysteroscopic Tissue Removal Systems
Modality
- Benchtop Systems
- Stand-Alone Systems
- Handheld Systems
End User
- Hospitals
- Diagnostic Laboratories
- Office-Based Setting
- Ambulatory Surgical Centres
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Key Questions Covered in the Hysteroscopy Systems Market Report
- The market survey also highlights projected sales growth for hysteroscopy systems market between 2019 and 2029
- The report offers insight into hysteroscopy systems demand outlook for forecast period 2019-2029
- Hysteroscopy systems market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
- Hysteroscopy systems market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain
Terminal Sterilization Market- Growing demand for terminal sterilization for drug products amongst end-user continues to drive demand for terminal sterilization. Furthermore, the introduction of new products and technological breakthroughs in the sterilization process would propel the terminal sterilization market forward. Because of increased awareness about diseases and infections caused by non-sterile environments, the terminal sterilization market has gotten a lot of attention in recent years. Aside from increased investment in hospital infrastructure, research and public health adaptation of terminal sterilization is on the rise.
Genitourinary Cancers Treatment Market- Prostate cancer, kidney cancer, bladder cancer, testicular cancer, and cancers of the penis are all cancers of the urinary and reproductive systems, and genitourinary cancers treatment refers to the treatments used to cure or slow the progression of these malignancies. The treatment of genitourinary malignancies is a specialist section of oncology that focuses on the urinary and reproductive systems. The market for genitourinary cancer treatment is being driven by an increase in the incidence of genitourinary tumors. Another factor boosting the market is the increase in the geriatric population suffering from the risk factors connected with genitourinary malignancies.
Pelvic Congestion Syndrome Treatment Market- Pelvic congestion syndrome is a painful disorder that affects the pelvic area. Problems with the veins near the pelvic area are the most common cause of this pain. Pelvic congestion syndrome is a prevalent problem in women between the ages of 20 and 50. For pelvic congestion syndrome treatment, doctors typically recommended medications to alleviate the discomfort. Hormonal therapy is also used to relieve congestion in the treatment of pelvic congestion syndrome. The market is projected to be driven by various treatment options for pelvic congestion syndrome. Hormonal therapy aids in the reduction of viscous vein congestion and blood flow.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR